Leptin, an adipocyte-derived hormone, contributes
|
|
- Duane Parks
- 5 years ago
- Views:
Transcription
1 Original Article Metformin Restores Leptin Sensitivity in High-Fat Fed Obese Rats With Leptin Resistance Yong-Woon Kim, 1 Jong-Yeon Kim, 1 Yong-Hoon Park, 2 So-Young Park, 1,3 Kyu-Chang Won, 4 Kwang-Hae Choi, 2 Jung-Yoon Huh, 1 and Ki-Hak Moon 5 To evaluate whether metformin enhances leptin sensitivity, we measured leptin sensitivity after 4 weeks of metformin treatment (300 mg/kg daily) in both standard chow and high-fat fed obese rats. Anorexic and fat-losing responses after intracerebroventricular leptin infusion for 7 days (15 g daily per rat) in standard chow rats were enhanced by metformin treatment, and these responses to leptin were attenuated in high-fat fed obese rats compared with age-matched standard chow rats. However, these responses to leptin were corrected by metformin treatment in high-fat fed obese rats. Moreover, serum concentrations of leptin and insulin were decreased dramatically by leptin in metformin-treated standard chow and high-fat fed obese rats. The hypothalamic phosphorylated AMP-activated protein kinase level was decreased by lower leptin dose in metformin-treated rats than in untreated rats. In an acute study, metformin treatment also increased the anorexic effect of leptin (5 g), and this was accompanied by an increased level of phosphorylated signal transducer and activator of transcription 3 in the hypothalamus. These results suggest that metformin enhances leptin sensitivity and corrects leptin resistance in high-fat fed obese rats and that a combination therapy including metformin and leptin would be helpful in the treatment of obesity. Diabetes 55: , 2006 Leptin, an adipocyte-derived hormone, contributes to body weight homeostasis by regulating food intake and energy expenditure (1). However, leptin is not widely used in the clinical field because obesity is accompanied by elevated serum leptin and responds poorly to the pharmacological administration of From the 1 Department of Physiology, College of Medicine, Yeungnam University, Daegu, Republic of Korea; 2 Department of Pediatrics, College of Medicine, Yeungnam University, Daegu, Republic of Korea; 3 Aging-Associated Vascular Disease Research Center, College of Medicine, Yeungnam University, Daegu, Republic of Korea; 4 Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Republic of Korea; 5 Department of Urology, College of Medicine, Yeungnam University, Daegu, Republic of Korea. Address correspondence and reprint requests to Yong-Woon Kim, MD, PhD, Department of Physiology, College of Medicine, Yeungnam University, #317-1, Daemyungdong, Namgu, Daegu , Republic of Korea. ywkim@med.yu.ac.kr. Received for publication 19 July 2005 and accepted in revised form 29 November AMPK, AMP-activated protein kinase; CRF, corticotrophin releasing factor; CSF, cerebrospinal fluid; pacc, phosphorylated acetyl-coa carboxylase; pampk, phosphorylated AMPK; pstat3, phosphorylated signal transducer and activator of transcription 3; STAT, signal transducer and activator of transcription by the American Diabetes Association. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. exogenous leptin, which ordinarily potently promotes fat mass loss and body weight reduction in lean subjects (2,3); moreover, this poor response of obese subjects is a characteristic of leptin resistance. Thus, the correction of leptin resistance in obese individuals would allow leptin to be used to treat obesity. Metformin, an oral biguanide insulin-sensitizing agent, inhibits hepatic glucose production, enhances the effects of insulin on glucose uptake in skeletal muscles and adipocytes, and decreases intestinal absorption of glucose (4 7). It is also well known that metformin administration reduces body weight (8,9). Moreover, metformin decreases leptin concentration in morbidly obese subjects (9,10) and in normal-weight healthy men (11). Although leptin concentration is closely related to body fat mass, the leptin-reducing effect of metformin cannot be fully explained by body weight reduction because metformin reduces leptin level even without changing body weight in normal-weight healthy men (11). However, the mechanisms by which metformin reduces body weight and leptin concentration are poorly understood. In addition, it has been recently reported that metformin targets AMP-activated protein kinase (AMPK), which is also activated by leptin (12 14). The above findings imply that a more delicate interaction takes place between metformin and leptin. We hypothesized that metformin increases leptin sensitivity and that the anorexic and leptin-reducing effects of metformin are a result of increased leptin sensitivity. RESEARCH DESIGN AND METHODS Male Sprague-Dawley rats were purchased from the Daehan Experimental Animal Center (Seoul, Korea) in a postweaning state. After 1 week of adaptation, the rats were divided into two groups, i.e., standard chow and high-fat fed groups. The animals were cared for in accordance with the principles of the Guide to the Care and Use of Experimental Animals of the Yeungnam Medical Center. The rats were housed individually under a 12-h light/dark cycle (from 0700 to 1900). Experimental design Experiment 1. To evaluate the leptin sensitizing effect of metformin, the standard chow rats were divided into three groups at 4 months of age: ad libitum fed (untreated) rats, metformin-treated (treated) rats, and a group of rats pair-fed with the treated rats. The pair-fed rats began the experiment 1 week later than the treated rats, and the amount of food consumed by the treated group was then provided to the pair-fed group in the morning. Each of these three animal groups were further divided into two experimental groups: the artificial cerebrospinal fluid (CSF)-infused group (vehicle) and the leptininfused group, which were matched for body weight and daily caloric intake (n 8 in each group). In addition to the above six experimental groups, different dosages of leptin (0, 0.6, 3, or 15 g leptin daily for treated rats and 0, 0.6, or 15 g leptin daily for untreated rats) were infused into standard chow rats to examine leptin dose responsiveness. We also measured the effects of short-term metformin treatment (300 mg/kg s.c. daily for 2 days) on the anorexic effect of leptin. Leptin (5 g) was 716 DIABETES, VOL. 55, MARCH 2006
2 Y.-W. KIM AND ASSOCIATES injected into the lateral ventricle through a chronically implanted catheter in unrestrained rats on the second day of metformin treatment. Food intake was measured at 6, 12, and 24 h after leptin injection. The body weights before leptin injection in metformin-treated and untreated rats were and g, respectively. To evaluate leptin signaling, the phosphorylated signal transducer and activator of transcription 3 (pstat3) level was measured in the hypothalamus 1 h after an intracerebroventricular injection of leptin (0, 0.1, or 1 g) in rats treated with metformin (300 mg/kg s.c. daily, two consecutive mornings) or saline. Leptin was injected 2 h after the second treatment of metformin. Experiment 2. To evaluate whether metformin can correct leptin resistance in a leptin-resistant rat model, high-fat fed obese rats were treated with metformin for 4 weeks. A leptin-resistant obese rat model was produced by a high-fat diet for 4 months. The high-fat diet was composed of butter, corn oil, sucrose, and casein (38, 21, 23, and 17%, respectively, of total calories) supplemented with vitamins (0.8%), minerals (1.9%), and methionine (0.15%). To confirm leptin resistance before starting metformin treatment, we took blood ( 400 l) from a tail vein under ethrane anesthesia to measure the serum leptin level after 12 weeks on a high-fat or standard chow diet. The serum leptin concentration was significantly elevated in high-fat fed obese rats compared with standard chow rats ( vs ng/ml, respectively; P 0.01). The high-fat fed obese rats were then divided into three groups as described above for standard chow rats (i.e., untreated, treated, and pair-fed rats) and these three animal groups were similarly further divided into vehicle and leptin groups (n 8 in each group). Experiment 3. To evaluate whether metformin has the same effect in a genetically obese animal model, metformin was administered to 7-month-old Otsuka Long-Evans Tokushima Fatty (OLETF) rats and their wild-type LETO rats for 3 weeks. Changes in food intake, body weight, leptin concentration were documented. The pathogenic defect in OLETF rats is a cholecystokinin A receptor defect in the hypothalamus, and these rats show severe fat depositions in visceral regions. Metformin treatment. Metformin (300 mg/kg daily) was dissolved in drinking water and administered orally for 4 weeks. Metformin concentrations in water were readjusted twice a week after measuring daily water intake. The untreated and pair-fed rats received drinking water without metformin ad libitum. Leptin or vehicle administration. Rats were infused with either vehicle or leptin (15 g daily) for 7 days into the lateral ventricle, using an osmotic minipump. On the morning of the experiment, rats were anesthetized with xylazine hydrochloride (8 mg/kg s.c.) and ketamine (90 mg/kg i.p.). A brain infusion cannula (Alzet, Cupertino, CA) was stereotaxically placed into the lateral ventricle, using the following coordinates: 1.3 mm posterior to bregma, 1.9 mm lateral to the midsagittal suture, and to a depth of 4.0 mm. A subcutaneous pocket was created using blunt dissection on the dorsal surface and an osmotic minipump (Alzet) was inserted. A catheter tube was connected from the brain infusion cannula to the osmotic minipump, and the brain infusion cannula was secured to the surface of the skull using a jeweler s screw and acrylic dental cement. The incision was closed with sutures, and rats were kept warm until fully recovered. The infusion rate used was 1 l/h. Tissue harvesting and preparation. Rats were anesthetized with pentobarbital (85 mg/kg i.p.). CSF was taken through a puncture into the fourth ventricle under stereotaxic fixation, blood samples were collected by heart puncture, and serum was harvested by a 10-min centrifugation in serum separator tubes. The circulatory system was perfused with 50 ml of cold saline, and retroperitoneal white adipose tissue and hypothalamus were excised. Tissues and serum were quick-frozen with liquid nitrogen and stored at 70 C. RT-PCR. Total RNA was extracted from hypothalamus, using a modification of the method of Chomczynski and Sacchi (15). Then, 1 g total RNA was reverse-transcribed into cdna using a Qiagen one-step RT-PCR kit (Hilden, Germany). The POMC sense primer sequence was CCCGAGAAACAGCAG CAGTG, and the antisense primer sequence was AGGGGGCCTTGGA GTGAGAA. The amplification was initiated at 50 C for 30 min, followed by 30 cycles consisting of denaturation at 94 C for 1 min, annealing at the appropriate primer-pair annealing temperature for 1 min, extension at 72 C for 1 min, and a final extension step of 10 min at 72 C. -Actin (sense: TCTACAAT GAGCTGCGTGTG, and antisense: GGTCAGGATCTTCATGAGGT) was used as an internal standard. The RT-PCR products were electrophoresed in 11.5% agarose gels and visualized by ethidium bromide staining. Western blot analysis. Protein (30 g) in hypothalamic lysate was separated on 10% polyacylamide gels and then transferred onto nitrocellulose membranes. Phosphorylated AMPK (pampk), phosphorylated acetyl-coa carboxylase (pacc), and pstat3 level were determined by blotting with their specific antibodies (Cell Signaling, Danvers, MA), and total levels of AMPK, ACC, and signal transducer and activator of transcription 3 (STAT3) were estimated in separate blots. In each case, anti-rabbit antibody linked to TABLE 1 The serum concentrations of leptin, insulin, and CRF in the experimental groups Leptin (ng/ml) Insulin (ng/ml) CRF (ng/ml) Standard chow Untreated Vehicle Leptin * Treated Vehicle Leptin Pair-fed Vehicle Leptin High-fat diet Untreated Vehicle * * Leptin Treated Vehicle Leptin Pair-fed Vehicle Leptin Data are means SE of eight rats per group. *P 0.05 vs. untreated vehicle standard chow rats; P 0.01 vs. untreated vehicle standard chow rats; P 0.01 vs. their vehicle rats; P 0.05 vs. their vehicle rats; P 0.05 vs. their treated leptin rats; P 0.05 vs. untreated vehicle high-fat fed obese rats. horseradish peroxidase was used as the secondary antibody. Blots were developed by enhanced chemiluminescence (Amersham Biosciences, Little Chalfont, Buckinghamshire, U.K.), and quantification was performed using Scion Image software. Measurements of leptin, insulin, and corticotrophin releasing factor. Serum leptin level was measured using a rat leptin radioimmunoassay kit (Linco Research, St. Charles, MO), CSF leptin using a leptin immunoassay kit (Quankine M; R&D Systems, Minneapolis, MN), serum insulin using a rat insulin enzyme immunosorbent assay kit (SPI-BIO, Massy, France), and serum corticotrophin releasing factor (CRF) level using a rat CRF enzyme immunosorbent assay kit (Phoenix Pharmaceuticals, Belmont, CA). Statistical analysis. Data are the means SE. Differences between the groups were analyzed by ANOVA, followed by a post hoc test for group comparisons. P 0.05 was considered statically significant. RESULTS Characteristics of the high-fat fed obese rats. The high-fat diet increased body weight significantly compared with the standard chow rats (P 0.05) from 4 weeks until the end of the experiment. The cumulative caloric intake in the high-fat fed obese rats at 4 months was 134% of that of standard chow rats. The retroperitoneal white adipose tissue mass of high-fat fed obese rats was increased by 2.5 times (P 0.001) that of standard chow rats. Serum leptin and insulin concentrations were also significantly higher in high-fat fed obese rats (P 0.01) (Table 1). The effect of metformin in the leptin-infused rats. Metformin treatment alone decreased the caloric intake and body weights of standard chow and high-fat fed obese rats, although these effects were more prominent in highfat fed obese rats (Fig. 1). The leptin treatment in standard chow rats significantly decreased daily caloric intake until day 7 compared with vehicle-administered rats. Moreover, tachyphylaxis developed in the metformin-un- DIABETES, VOL. 55, MARCH
3 METFORMIN ENHANCES LEPTIN SENSITIVITY FIG. 1. Body weight (A) and daily calorie intake (B) in the standard chow and high-fat fed obese rats. Metformin treatment (300 mg/kg daily) was started 14 weeks after high-fat or standard chow dieting. Data are the means SE of eight rats per group., untreated standard chow; f, treated standard chow; E, untreated high-fat fed; F, treated high-fat fed. treated leptin-treated rats from day 5. In high-fat fed obese rats, leptin also suppressed daily caloric intake, although this suppression of appetite was less than that seen in standard chow rats. Leptin treatment reduced body weight by 10% in standard chow rats and by 5% in high-fat fed obese rats (Fig. 3). Metformin treatment was observed to enhance leptin s anorexic and body weight losing effects in standard chow rats and to suppress the development of tachyphylaxis. Metformin treatment also enhanced the anorexic and body weight losing effects of leptin in high-fat fed obese rats. Caloric intake and body weight were also measured after intracerebroventricular leptin infusion in pair-fed rats, excluding the effect of food restriction on the leptin effect. Body weight decreased more slowly in pair-fed rats than in metformin-treated standard chow rats, but the suppression of appetite due to leptin treatment in pair-fed rats did not reach the level of that observed in metformin-treated rats. Leptin treatment reduced retroperitoneal white adipose tissue mass in standard chow rats; however, it did not reduce this mass in high-fat fed obese rats, which is a characteristic of leptin resistance. Metformin treatment reduced retroperitoneal white adipose tissue mass in high-fat fed obese rats and in standard chow rats. Noticeably, retroperitoneal white adipose tissue mass was markedly reduced by leptin treatment in both standard chow and high-fat fed obese rats treated with metformin compared with their untreated counterparts and pair-fed rats. To clarify the leptin-sensitizing effect of metformin, we measured the dose-responsiveness of leptin in standard chow rats. Accordingly, different dosages of leptin were infused into metformin-treated and untreated standard chow rats. In treated rats, leptin s anorexic and body weight losing effects were apparent from 0.6 g leptin daily, and these effects were increased on increasing the dose. However, 0.6 g leptin daily failed to reduce the daily caloric intake as well as body weight in untreated rats. Moreover, visceral fat mass was reduced dramatically by leptin treatment even at 0.6 g daily in metformintreated standard chow rats; however, this dose had no significant effect on untreated standard chow rats. Cumulative caloric intake and body weight decreased in metformin-treated standard chow rats in a leptin dose dependent manner (Fig. 2). Serum levels of leptin, insulin, and CRF and the CSF leptin concentration. The serum levels of leptin and insulin were elevated in high-fat fed obese rats, which did not respond to leptin treatment. Metformin treatment per se decreased serum concentrations of leptin and insulin in high-fat fed obese rats, and these levels were further decreased by leptin treatment. Combined treatment with metformin and leptin dramatically decreased serum concentrations of leptin and insulin in standard chow rats. The serum CRF concentration was higher in high-fat fed obese rats than in standard chow rats, and this was not changed by leptin treatment in high-fat fed obese rats, but it was reduced by leptin in standard chow rats. Metformin did not change the CRF level in standard chow rats, but it reduced the CRF level in high-fat fed obese rats. Leptin treatment reduced the serum leptin level in pair-fed highfat fed obese rats, but no significant change in CRF level was observed in these rats (Table 1). No significant difference was observed between the CSF leptin concentrations in standard chow and high-fat fed obese rats, despite hyperleptinemia in high-fat fed obese rats. Metformin treatment significantly increased the CSF leptin level in both standard chow and high-fat fed obese rats (P 0.05), and the CSF-to-serum leptin ratio was increased in treated rats (Fig. 4). Proopiomelanocortin mrna expressions and the levels of pampk and pacc in the hypothalamus. Proopiomelanocortin (POMC) expression was significantly decreased in the hypothalamus of high-fat fed obese rats compared with standard chow rats, and no significant elevation in POMC expression was observed when intracerebroventricular leptin was administered to high-fat fed obese rats, whereas leptin increased hypothalamic POMC expression in standard chow rats. However, hypothalamic POMC expression was elevated by leptin treatment in the metformin-treated high-fat fed obese rats, which provided further evidence of a correction of leptin resistance in the hypothalamus. Expressions of neuropeptide Y and agoutirelated protein in the hypothalamus were not changed significantly among the experimental groups (data not shown). Hypothalamic pampk level was decreased by leptin treatment but not by metformin treatment in standard chow rats. However, a lower dose of leptin was required to decrease the hypothalamic pampk level in metformin-treated rats than in untreated rats. High-fat feeding did not affect pampk level in the hypothalamus 718 DIABETES, VOL. 55, MARCH 2006
4 Y.-W. KIM AND ASSOCIATES with untreated rats. Moreover, the anorexic effect of leptin was maintained until 24 h in metformin-treated rats, whereas its anorexic effect was blunted from 6 h after leptin injection in untreated rats. We measured the pstat3 level in the hypothalamus 1 h after intracerebroventricular leptin injection (0, 0.1, or 1 g) to analyze leptin signaling. It was found that the pstat3 level after injection of 0 or 0.1 g leptin increased more in treated rats than in untreated rats. However, the maximal pstat3 level (at 1 g leptin) was no different in metformin-treated and untreated rats (Fig. 6). The effects of metformin in OLETF and LETO rats. Metformin administered for 3 weeks decreased the mean cumulative caloric intake, body weight, and visceral fat mass by 46.9, 19.4, and 41.4%, respectively, in OLETF rats. These represent augmented responses to metformin compared with similar responses observed in LETO rats, in which the mean cumulative caloric intake, body weight, and visceral fat mass were reduced by 24.5, 12.5, and 29.4%, respectively, versus untreated LETO rats. Metformin treatment decreased serum leptin concentrations in both OLETF and LETO rats compared with their untreated counterparts ( vs , P 0.01; and vs ng/ml, P 0.01; respectively). Moreover, serum leptin levels in metformin-treated OLETF and LETO rats showed positive correlations with percentage reductions in food intake (Fig. 7). FIG. 2. Effects of different dosages of leptin (L) on body weight (A), cumulative caloric intake (B), and retroperitoneal white adipose tissue (RT-WAT) weights (C) in metformin-treated or untreated standard chow rats. Different dosages of leptin (0, 0.6, 3, or 15 g daily) were infused for 7 days. Data are the means SE of eight rats per group., untreated/0 g leptin; f, untreated/0.6 g leptin;, untreated/15 g leptin; E, treated/0 g leptin; F, treated/0.6 g leptin;, treated/ 3 g leptin; Œ, treated/15 g leptin. *P < 0.05; **P < 0.01; ***P < BW, body weight; Lep, leptin; Veh, vehicle. (data not shown). Changes in hypothalamic pacc level, a downstream target of AMPK, revealed the same pattern as described for pampk (Fig. 5). The effects of short-term metformin treatment on the anorexic effect of leptin and leptin signaling. Metformin treatment for 2 days enhanced the anorexic effect of the intracerebroventricular leptin injection compared DISCUSSION The current study demonstrates that the anorexic and fat-losing effects of intracerebroventricular leptin are more prominent and that a lower dose of leptin is required to induce these effects in metformin-treated rats than in untreated rats. The observed dramatic decrease in the serum levels of leptin and insulin after combination therapy with metformin and leptin support our findings. Moreover, metformin corrected leptin resistance in dietinduced obese rats. It is well known that metformin has an anorexic effect (16); however, the mechanism underlying this effect is not clear. Several studies (8,9,17) have reported that the anorexic effect of metformin is attributable to an enhanced insulin effect. Although chronic intracerebroventricular infusion of insulin induces anorexia (18,19) and insulin is associated with anorexic signaling in the hypothalamus (20 22), our findings suggest that leptin is more responsible for the anorexic effect of metformin than insulin for the following reasons. First, a greater reduction in insulin concentration occurred after combined treatment with metformin and leptin than after leptin treatment alone, while appetite was suppressed more profoundly in the combined therapy group. Second, percentage reductions in food intake showed no significant correlation with serum insulin concentrations (data not shown) but were positively correlated with serum leptin levels in OLETF and LETO rats. Third, metformin treatment increased CSF leptin concentrations in both standard chow and high-fat fed obese rats compared with the untreated rats. Because defective leptin transport through the blood-brain barrier is a possible mechanism of leptin resistance (23 25), which was also shown by the current study, the increase in CSF leptin level may mediate the anorexic effect of metformin. Leptin signal transduction involves the phosphorylation of STAT3 in the hypothalamus (26,27), which is associated DIABETES, VOL. 55, MARCH
5 METFORMIN ENHANCES LEPTIN SENSITIVITY FIG. 3. Comparisons of the effects of metformin (followed by intracerebroventricular leptin infusion) in standard chow (SC) and high-fat fed obese (HFO) rats on body weight (A and D), cumulative caloric intake (B and E), and retroperitoneal white adipose tissue (RT-WAT) weights (C and F). Leptin (15 g daily) or vehicle (artificial CSF) was infused for 7 days. Data are the means SE of eight rats per group., untreated vehicle; f, untreated leptin; E, treated vehicle; F, treated leptin;, pair-fed vehicle; Œ, pair-fed leptin.*p < 0.05; **P < 0.01; ***P < Lep, leptin; Veh, vehicle. with elevated expression of POMC, an anorexigenic peptide. Moreover, impaired STAT signaling has been demonstrated in leptin-resistant aged obese rats and in db/db mice (28,29). To clarify the mechanism underlying the enhanced effect of leptin in metformin-treated rats, we measured the pstat3 level in the hypothalamus after short-term treatment with metformin and/or leptin injection. The hypothalamic pstat3 level was increased by metformin treatment alone and was increased more by leptin treatment. The phosphorylated STAT3 level was also increased by directly injecting metformin into the lateral ventricle. Consistent with this finding, the anorexic effect of intracerebroventricular leptin during 24 h was more profound in metformin-treated rats than in untreated rats. Although little information about the effect of metformin on the brain is available in the literature, we suggest that metformin s anorexic effect is mediated by the STAT3 signaling pathway. Increased pstat3 in the hypo- 720 DIABETES, VOL. 55, MARCH 2006
6 Y.-W. KIM AND ASSOCIATES FIG. 4. Concentrations of leptin in CSF (A), serum (B), and their ratios (C) in standard chow (SC) and high-fat fed obese (HFO) rats. Data are the means SE of eight rats per group. *P < 0.05 and **P < 0.01 vs. untreated standard chow rats; P < 0.05 and P < 0.01 vs. untreated high-fat fed obese rats., untreated; f, treated. thalamus by metformin may, at least in part, be attributable to the enhanced effect of leptin because we were unable to eliminate leptin from the CSF. Rouru et al. s (17) report describes the anorexic effect of metformin in Zucker rats, which do not have an intact leptin receptor, which suggests that the anorexic effect of metformin bypasses the leptin receptor. However, we observed a more remarkable anorexic effect in OLETF rats after administering the same dose (300 mg/kg daily) of metformin than was reported by Rouru et al. (17). Taken together, we believe that metformin and leptin may share a common energy balance signaling pathway. We also observed that a decrease in hypothalamic pampk level was induced by a lower dose of leptin in treated rats than in untreated rats, whereas metformin alone did not change the pampk level in the hypothalamus. Because pampk is related to the fuel-sensing mechanism in the hypothalamus, and because it is decreased by leptin in the hypothalamus (30,31), the reduced level of pampk in the hypothalamus observed in the current study FIG. 5. Expression of proopiomelanocortin (POMC) (A) and levels of pampk (B) and phosphorylated acetyl CoA carboxylase (pacc) (C) in the hypothalamus after leptin or vehicle infusion in metformin-treated or untreated standard chow (SC) and high-fat fed obese (HFO) rats. Representative blots are shown in each panel. Data are the means SE of eight rats per group. *P < 0.05 vs. their vehicle groups. Lep, leptin; Veh, vehicle. DIABETES, VOL. 55, MARCH
7 METFORMIN ENHANCES LEPTIN SENSITIVITY FIG. 6. Cumulative food intake during 24 h after intracerebroventricular (i.c.v) injection of leptin (5 g) in unrestrained rats (A) and pstat3 level in the hypothalamus 1 h after leptin injection (B). Data are the means SE of five rats per group. *P < 0.05 and **P < 0.01 vs. their untreated vehicle; P < 0.01 vs. treated vehicle. Met, metformin; SC and s.c., subcutaneous. might be associated with enhanced leptin sensitivity. Moreover, metformin increased hypothalamic POMC expression by leptin treatment in high-fat fed obese rats, whereas this was not observed in untreated high-fat fed obese rats. Because the effect of leptin is associated with the activation of POMC (32), failure to activate POMC expression by leptin is evidence of leptin resistance, as was shown by untreated high-fat fed obese rats in the current study. Moreover, recovery of the POMC activating effect of leptin suggests the correction of leptin resistance. In high-fat fed obese rats, metformin treatment reduced body weight and food intake more prominently than in standard chow rats. Moreover, although metformin treatment alone did not normalize visceral fat or serum leptin concentration completely in high-fat fed obese rats, a combination of metformin and intracerebroventricular leptin infusion did normalize these parameters. The elevated serum CRF level, a hypothalamic hormone involved in feeding regulation (33), was decreased by metformin alone in high-fat fed obese rats, and this was further decreased by metformin and leptin combination therapy, suggesting that the metformin/leptin combination could be useful in the treatment of obesity. We added the pair-fed group to this study to eliminate food restriction effects induced by metformin treatment. The anorexic and visceral fat shedding effects of leptin were slightly enhanced in pair-fed high-fat fed obese rats, which is consistent with other reports (34,35). However, this degree of enhancement did not reach that of metformin-treated high-fat fed obese rats. Moreover, a dramatic decrease in biochemical parameters was observed in metformin-treated high-fat fed obese rats but not in pair-fed rats. In summary, the anorexic effect of metformin appears to be related to the action of leptin. Moreover, metformin was found to enhance the anorexic and fat-losing effects of leptin in standard chow rats and to restore leptin sensitivity in high-fat fed obese rats with leptin resistance. Our findings indicate that metformin and leptin combination therapy could be useful for the treatment of obesity. 722 DIABETES, VOL. 55, MARCH 2006
8 Y.-W. KIM AND ASSOCIATES FIG. 7. Effects of metformin treatment (300 mg/kg daily) for 3 weeks on body weight (BW) (A), daily food intake (B), and retroperitoneal white adipose tissue weights (C) in OLETF and LETO rats. A significant correlation was found between serum leptin concentrations and percentage reductions in food intake (D). Data are the means SE of 7 8 rats per group. *P < 0.05 and **P < 0.01 vs. their untreated rats. ACKNOWLEDGMENTS This work was supported by the Korean Research Foundation Grant funded by the Korean Government (R ) and the Korea Science and Engineering Foundation (KOSEF; R ). REFERENCES 1. Halaas JL, Booze C, Blair-West J, Fidahusein N, Denton DA, Friedman JM: Physiological response to long term peripheral and central leptin infusion in lean and obese mice. Proc Natl Acad Sci 94: , Widdowson PS, Upton R, Buckingham R, Arch J, Williams G: Inhibition of food response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity. Diabetes 46: , Shek EW, Scarpace PJ: Resistance to the anorexic and thermogenic effects of centrally administrated leptin in obese aged rats. Regul Pept 92:65 71, Hundal HG, Ramlal T, Reyes R, Leiter LA: Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells. Endocrinology 131: , Klip A, Guma A, Ramlal T, Bilan PJ, Lam L, Leiter LA: Stimulation of hexose transport by metformin in L6 muscle cells in culture. Endocrinology 130: , Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R: Effects of metformin on spontaneous and clomiphine-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338: , Wiernsperger NF, Bailey CJ: The antihyperglycemic effect of metformin: therapeutic and cellular mechanisms. Drugs 58:31 39, Paolisso G, Amato L, Eccellente R, Gambardella A, Tagliamonte MR, Varricchio G, Carella C, Giugliano D, D Onofrio F: Effect of metformin on food intake in obese subjects. Eur J Clin Invest 28: , Kay JP, Alemzadeh R, Langley G, D Angelo L, Smith P, Holshouser S: Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metabolism 50: , Glueck CJ, Fontaine RN, Wang P, Subbiah MTR, Weber K, Illig E, Streicher P, Sieve-Smith L, Tracy T, Kang JE, McCullough P: Metformin reduces weight, centropedal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism 5097: , Fruehwald-Schultes B, Oltmanns KM, Toschek B, Sopke S, Kern W, Born KJ, Fehm HL, Peters A: Short-term treatment with metformin decreases DIABETES, VOL. 55, MARCH
9 METFORMIN ENHANCES LEPTIN SENSITIVITY serum leptin concentration without affecting body weight and body fat content in normal-weight healthy men. Metabolism 51: , Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE: Role of AMP-activated kinase in mechanism of metformin action. J Clin Invest 108: , Hawley SA, Gadalla AE, Olsen GS, Hardie DG: The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51: , Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB: Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: , Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenolchloroform extraction. Anal Biochem 162: , Komori T, Yoshida F, Nakamura J, Miyazaki S, Miura H, Iguchi A: Metformin ameliorates treatment of obese type 2 diabetic patients with mental retardation; its effect on eating behavior and serum leptin levels. Exp Clin Endocrinol Diabetes 112: , Rouru J, Pesonen U, Koulu M, Huupponen R, Santti E, Virtanen K, Rouvari T, Jhanwar-Uniyal M: Anorexic effect of metformin in obese Zucker rats: lack of evidence for the involvement of neuropeptide Y. Eur J Pharmacol 273:99 106, Brief DJ, Davis JD: Reduction of food intake and body weight by chronic intraventricular insulin infusion. Brain Res Bull 12: , Ikeda H, West DB, Pustek JJ: Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats. Appetite 7: , Kaiyala KJ, Woods SC, Schwartz MW: New model for the regulation of energy balance and adiposity by the central nervous system. Am J Clin Nutr 62 (5 Suppl.):1123S 1134S, Niswender KD, Morrison CD, Clegg DJ, Olson R, Baskin DG, Myers MG, Seeley RJ, Schwartz MW: Insulin activation of phosphatidyl 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 52: , Niswender KD, Schwartz MW: Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front Neuroendocrinol 24:1 10, Caro JF, Kolaczynski JW, Nyce MR, Ohannesian JP, Opentanova I, Goldman WH, Lynn RB, Zhang PL, Sinha MK, Considine RV: Decreased cerebrospinal-fluid/serum leptin ratio in obesity, a possible mechanism for leptin resistance. Lancet 348: , Couce ME, Green D, Brunetto A, Achim C, Lloyd RV, Burguera B: Limited brain access for leptin in obesity. Pituitary 4: , Nam SY, Kratzsch J, Kim KW, Kim KR, Lim SK, Marcus C: Cerebrospinal fluid and plasma concentrations of leptin, NPY, and alpha-msh in obese women and their relationship to negative energy balance. J Clin Endocrinol Metab 86: , Vaisse C, Halaas JL, Horvath CM, Darnell JE, Stoffel M, Friedman JM: Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 14:95 97, McCowen K, Chow J, Smith RJ: Leptin signaling in the hypothalamus of normal rats in vivo. Endocrinology 139: , Ghilardi N, Ziegler S, Wiestner A, Stoffel A, Heim MH, Skoda RC: Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA93: , Scarpace PJ, Matheny M, Tumer N: Hypothalamic leptin resistance is associated with impaired leptin signal transduction in aged obese rats. Neuroscience 104: , Andersson U, Filipsson K, Abbott CR, Woods A, Smith K, Bloom SR, Carling D, Small CJ: AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 279: , Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, Kahn BB: AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428: , Kim YW, Choi DW, Park YH, Huh JY, Won KC, Choi KH, Park SY, Kim JY, Lee SK: Leptin-like effects of MTII are augmented in MSG-obese rats. Regul Pept 127:63 70, Masaki T, Yoshimichi G, Chiba S, Yasuda T, Noguchi H, Kakuma T, Sakata T, Yoshimatsu H: Corticotropin-releasing hormone-mediated pathway of leptin to regulate feeding, adiposity, and uncoupling protein expression in mice. Endocrinology 144: , Fernandez-Galaz C, Fernandez-Agullo T, Perez C, Peralta S, Arribas C, Andres A, Carrascosa JM, Ros M: Long-term food restriction prevents ageing-associated central leptin resistance in Wistar rats. Diabetologia 45: , Levin BE, Dunn-Meynell AA: Reduced central leptin sensitivity in rats with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 283:R941 R948, DIABETES, VOL. 55, MARCH 2006
BIOL212 Biochemistry of Disease. Metabolic Disorders - Obesity
BIOL212 Biochemistry of Disease Metabolic Disorders - Obesity Obesity Approx. 23% of adults are obese in the U.K. The number of obese children has tripled in 20 years. 10% of six year olds are obese, rising
More informationMethod of leptin dosing, strain, and group housing influence leptin sensitivity in high-fat-fed weanling mice
Am J Physiol Regul Integr Comp Physiol 284: R87 R100, 2003; 10.1152/ajpregu.00431.2002. Method of leptin dosing, strain, and group housing influence leptin sensitivity in high-fat-fed weanling mice HEATHER
More informationIntracerebroventricular Injection of Metformin Induces Anorexia in Rats
Original Article Oesity and Metaolic Syndrome http://dx.doi.org/1.493/dmj.212.36.4.293 pissn 2233-679 eissn 2233-687 D I A B E T E S & M E T A B O L I S M J O U R N A L Intracereroventricular Injection
More informationLong-term food restriction prevents ageing-associated central leptin resistance in wistar rats
Diabetologia (2002) 45:997 1003 DOI 10.1007/s00125-002-0851-4 Long-term food restriction prevents ageing-associated central leptin resistance in wistar rats C. Fernández-Galaz 1, T. Fernández-Agulló 1,
More informationLeptin Intro/Signaling. ATeamP: Angelo, Anthony, Charlie, Gabby, Joseph
Leptin Intro/Signaling ATeamP: Angelo, Anthony, Charlie, Gabby, Joseph Overview Intro to Leptin Definition & Sources Physiology Bound vs. Free Receptors Signaling JAK/STAT MAPK PI3K ACC Experimental findings
More informationTHEMED SECTION: ADVANCES IN NUTRITIONAL PHARMACOLOGY RESEARCH PAPER
THEMED SECTION: ADVANCES IN NUTRITIONAL PHARMACOLOGY RESEARCH PAPER The soluble leptin receptor neutralizes leptin-mediated STAT3 signalling and anorexic responses in vivo Jiejin Zhang 1 and Philip J Scarpace
More informationThe role of leptin in leptin resistance and obesity
Physiology & Behavior 88 (2006) 249 256 The role of leptin in leptin resistance and obesity Yi Zhang a,b, Philip J. Scarpace b, a Research Service, Department of Veterans Affairs Medical Center, Gainesville,
More informationAppeal decision. Appeal No USA HILL'S PET NUTRITION, INC. Osaka, Japan
Appeal decision Appeal No. 2015-17056 USA Appellant HILL'S PET NUTRITION, INC. Osaka, Japan Patent Attorney MURAI, Koji The case of appeal against the examiner's decision of refusal of Japanese Patent
More informationYiying Zhang, PhD Research Scientist. Research Summary:
Yiying Zhang, PhD Research Scientist Research Summary: Address: Naomi Berrie Diabetes Center at Columbia University Medical Center Russ Berrie Medical Science Pavilion 1150 St. Nicholas Avenue New York,
More informationMales- Western Diet WT KO Age (wks) Females- Western Diet WT KO Age (wks)
Relative Arv1 mrna Adrenal 33.48 +/- 6.2 Skeletal Muscle 22.4 +/- 4.93 Liver 6.41 +/- 1.48 Heart 5.1 +/- 2.3 Brain 4.98 +/- 2.11 Ovary 4.68 +/- 2.21 Kidney 3.98 +/-.39 Lung 2.15 +/-.6 Inguinal Subcutaneous
More informationPhilip J. Scarpace, Michael Matheny, Yi Zhang, Kit-Yan Cheng, and Nihal Tümer
0022-3565/07/3202-706 712 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 320, No. 2 U.S. Government work not protected by U.S. copyright 112813/3169071 JPET 320:706 712, 2007 Printed in
More informationIntroduction. Leptin secretion after a high-fat meal in normal-weight rats: strong predictor of long-term body fat accrual on a high-fat diet
Leptin secretion after a high-fat meal in normal-weight rats: strong predictor of long-term body fat accrual on a high-fat diet - Diet - Activity - Genetics etc. Introduction Obesity - Cardiovascular disease
More informationBALANCING THE SCALES USING A NOVEL CELLULAR ENERGY SENSOR
The West London Medical Journal 2010 Vol 2 No 4 pp 29-35 BALANCING THE SCALES USING A NOVEL CELLULAR ENERGY SENSOR Sairah Akbar The topic of obesity is rarely out of the public eye with an increasingly
More informationObesity in aging: Hormonal contribution
Obesity in aging: Hormonal contribution Hormonal issues in obesity and aging Hormonal role in regulation of energy balance Genetic component in hormonal regulation Life style contribution to hormonal changes
More informationHormones. Prof. Dr. Volker Haucke Institut für Chemie-Biochemie Takustrasse 6
Hormones Prof. Dr. Volker Haucke Institut für Chemie-Biochemie Takustrasse 6 Tel. 030-8385-6920 (Sekret.) 030-8385-6922 (direkt) e-mail: vhaucke@chemie.fu-berlin.de http://userpage.chemie.fu-berlin.de/biochemie/aghaucke/teaching.html
More informationObesity: The role of hypothalamic AMP-activated protein kinase in body weight regulation
The International Journal of Biochemistry & Cell Biology 37 (2005) 2254 2259 Medicine in focus Obesity: The role of hypothalamic AMP-activated protein kinase in body weight regulation Woo Je Lee, Eun Hee
More informationFigure 1: The leptin/melanocortin pathway Neuronal populations propagate the signaling of various molecules (leptin, insulin, ghrelin) to control
Leptin Deficiency Introduction The leptin/melanocortin pathway plays a key role in the hypothalamic control of food intake. It is activated following the systemic release of the adipokine leptin (LEP)
More informationChronic Stimulation of Leptin on Food Intake and Body Weight after Microinjection into the Ventromedial Hypothalamus of Conscious Rats
TAJ December 2006; Volume 19 Number 2 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Original Article Chronic Stimulation of Leptin on Food Intake and Body Weight after Micro into the
More informationPeripubertal, leptin-deficient ob/ob female mice were used in an investigation of
ESSICK-BROOKSHIRE, ELIZABETH ANN, M.S. The Effects of Peripherally Administered 17-β Estradiol and BIBP3226, a NPY Y1 Receptor Antagonist, on Food Intake, Body Mass, Reproductive Development and Behavior
More informationLow ambient temperature lowers cholecystokinin and leptin plasma concentrations in adult men
ISPUB.COM The Internet Journal of Gastroenterology Volume 7 Number 2 Low ambient temperature lowers cholecystokinin and leptin plasma concentrations in adult men M Pizon, P Tomasic, K Sztefko, Z Szafran
More informationRole of fatty acids in the development of insulin resistance and type 2 diabetes mellitus
Emerging Science Role of fatty acids in the development of insulin resistance and type 2 diabetes mellitus George Wolf Insulin resistance is defined as the reduced responsiveness to normal circulating
More informationDefective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin Resistance
Cell Metabolism, Volume 11 Supplemental Information Defective Hepatic Autophagy in Obesity Promotes ER Stress and Causes Insulin Resistance Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, and Gökhan S. Hotamisligil
More informationAlthough obesity is a major cause of human essential
Does Obesity Induce Resistance to the Long-Term Cardiovascular and Metabolic Actions of Melanocortin 3/4 Receptor Activation? Alexandre A. da Silva, Jay J. Kuo, Lakshmi S. Tallam, Jiankang Liu, John E.
More informationNeurophysiology of the Regulation of Food Intake and the Common Reward Pathways of Obesity and Addiction. Laura Gunter
Neurophysiology of the Regulation of Food Intake and the Common Reward Pathways of Obesity and Addiction Laura Gunter The Brain as the Regulatory Center for Appetite The brain is the integration center
More informationInhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle
Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle Seung Hun Cha*, Zhiyuan Hu*, Shigeru Chohnan, and M. Daniel Lane* *Department of Biological
More informationHomeostasis and Mechanisms of Weight Regulation
Homeostasis and Mechanisms of Weight Regulation Purpose In this activity students will investigate how negative feedback mechanisms function to maintain homeostatic balance using a recently discovered
More informationWEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH
MENOPAUSE WHEN DOES IT OCCUR? The cessation of the menstrual cycle for one year. WEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH Jan Schroeder, Ph.D. Chair of The Department of Kinesiology California State
More informationChapter 12. Ingestive Behavior
Chapter 12 Ingestive Behavior Drinking a. fluid compartments b. osmometric thirst c. volumetric thirst Eating a. energy sources b. starting a meal c. stopping a meal d. eating disordersd Drinking a. fluid
More informationAMPK. Tomáš Kučera.
AMPK (AMP- ACTIVATED PROTEIN KINASE ) Tomáš Kučera tomas.kucera@lfmotol.cuni.cz Department of Medical Chemistry and Clinical Biochemistry 2nd Faculty of Medicine, Charles University in Prague and Motol
More informationGPR120 *** * * Liver BAT iwat ewat mwat Ileum Colon. UCP1 mrna ***
a GPR120 GPR120 mrna/ppia mrna Arbitrary Units 150 100 50 Liver BAT iwat ewat mwat Ileum Colon b UCP1 mrna Fold induction 20 15 10 5 - camp camp SB202190 - - - H89 - - - - - GW7647 Supplementary Figure
More informationEffect of Immune Challenge on Different Genotypes: How Sick Do They Get?
Introduction Effect of Immune Challenge on Different Genotypes: How Sick Do They Get? M.T. Leininger, C.P. Portocarrero, C.A. Bidwell, M.E. Spurlock, J.N. Nielsen, and K.L. Houseknecht Department of Animal
More informationSupplemental methods. Total RNA was extracted from the stomach, liver, pancreas, pituitary, and
Supplemental methods Real-time quantitative RT-PCR and Semi-quantitative PCR Total RNA was extracted from the stomach, liver, pancreas, pituitary, and hypothalamus as previously described (). Primers and
More informationCopyright : 2002, Blackwell Science Ltd
Deakin Research Online Deakin University s institutional research repository DDeakin Research Online Research Online This is the author s final peer reviewed version of the item published as: Sanigorski,
More informationCentral injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents
Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents Jarrad M Scarlett 1,,1, Jennifer M Rojas 1,1, Miles E Matsen 1, Karl J Kaiyala 3, Darko
More informationInhibition of 11β-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice
Diabetologia (2006) 49: 1333 1337 DOI 10.1007/s00125-006-0239-y SHORT COMMUNICATION S. J. Y. Wang. S. Birtles. J. de Schoolmeester. J. Swales. G. Moody. D. Hislop. J. O Dowd. D. M. Smith. A. V. Turnbull.
More informationSupplementary Figure 1) GABAergic enhancement by leptin hyperpolarizes POMC neurons A) Representative recording samples showing the membrane
Supplementary Figure 1) GABAergic enhancement by leptin hyperpolarizes POMC neurons A) Representative recording samples showing the membrane potential recorded from POMC neurons following treatment with
More informationa Supplementary Figure 1 Celastrol Withaferin A Individual drugs
Supplementary Figure 1 a 17 27 HSPA1A SLC7A11 HMOX1 GSTA1 DUSP4 GML CHAC1 CDKN1A GSTA4 CA6 BHLHE41 NR1D1 HSPB1 PTX3 HP NFKBIA VDR MVD HAS2 ANGPT1 WDR6 TGFB3 IDI1 VCAM1 H1F HMGCS1 CXCL5 STEAP4 NOS2 b Enrichment
More informationA synergistic anti-obesity effect by a combination of capsinoids and cold temperature through the promotion of beige adipocyte biogenesis
A synergistic anti-obesity effect by a combination of capsinoids and cold temperature through the promotion of beige adipocyte biogenesis Kana Ohyama, 1,2 Yoshihito Nogusa, 1 Kosaku Shinoda, 2 Katsuya
More informationAMPK. Tomáš Kuc era. Ústav lékar ské chemie a klinické biochemie 2. lékar ská fakulta, Univerzita Karlova v Praze
AMPK (AMP- ACTIVATED PROTEIN KINASE ) Tomáš Kuc era Ústav lékar ské chemie a klinické biochemie 2. lékar ská fakulta, Univerzita Karlova v Praze 2013 AMPK AMP-ACTIVATED PROTEIN KINASE present in all eukaryotic
More informationDigestion: Endocrinology of Appetite
Digestion: Endocrinology of Dr. Ritamarie Loscalzo Medical Disclaimer: The information in this presentation is not intended to replace a one on one relationship with a qualified health care professional
More informationCNS Control of Food Intake. Adena Zadourian & Andrea Shelton
CNS Control of Food Intake Adena Zadourian & Andrea Shelton Controlling Food Intake Energy Homeostasis (Change in body adiposity + compensatory changes in food intake) Background Information/Review Insulin
More informationSuccessful completion of Phase I clinical trial of AMPK activator O304
Successful completion of Phase I clinical trial of AMPK activator O304 O304 is safe and very well tolerated in young healthy subjects, in middle aged obese subjects, and in type 2 diabetics in combination
More informationTable 1. Oligonucleotides and RT-PCR conditions Supplementary Material and Methods Fig. 1
Table 1. Oligonucleotides and RT-PCR conditions. Overview of PCR templates, gene accession number of sequences used as template, product size, annealing temperatures and optimal cycles, cdna and MgCl 2
More informationOverall Energy metabolism: Integration and Regulation
Overall Energy metabolism: Integration and Regulation We have discussed various fuels which are oxidized via different catabolic pathways to generate ATP, or reducing equivalents required to carry out
More informationJaemin Lee, Ph.D. Department of New Biology Daegu Gyeongbuk Institute of Science and Technology (DGIST)
Jaemin Lee, Ph.D. Department of New Biology Daegu Gyeongbuk Institute of Science and Technology (DGIST) No Actual or Potential Conflict of Interest https://www.flickr.com/photos/luchoedu/2453267732/ 1985
More informationInternal Regulation II Energy
Internal Regulation II Energy Reading: BCP Chapter 16 lookfordiagnosis.com Homeostasis Biologically, what is necessary for life is a coordinated set of chemical reactions. These reactions take place in
More informationSupplementary Materials for
www.sciencesignaling.org/cgi/content/full/8/407/ra127/dc1 Supplementary Materials for Loss of FTO in adipose tissue decreases Angptl4 translation and alters triglyceride metabolism Chao-Yung Wang,* Shian-Sen
More informationMotivation 1 of 6. during the prandial state when the blood is filled
Motivation 1 of 6 I. INTRODUCTION A. Motivation: a condition (usually internal) that initiates, activates, or maintains goal-directed behavior. B. Archery analogy 1. undrawn bow has no potential energy
More informationGeneral Laboratory methods Plasma analysis: Gene Expression Analysis: Immunoblot analysis: Immunohistochemistry:
General Laboratory methods Plasma analysis: Plasma insulin (Mercodia, Sweden), leptin (duoset, R&D Systems Europe, Abingdon, United Kingdom), IL-6, TNFα and adiponectin levels (Quantikine kits, R&D Systems
More informationLean rats with hypothalamic pro-opiomelanocortin overexpression exhibit greater diet-induced obesity and impaired central melanocortin responsiveness
Diabetologia (27) 5:149 1499 DOI 1.7/s125-7-685-1 ARTICLE Lean rats with hypothalamic pro-opiomelanocortin overexpression exhibit greater diet-induced obesity and impaired central melanocortin responsiveness
More informationTwo defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity
Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity Karim El-Haschimi, Dominique D. Pierroz, Stanley M. Hileman, Christian Bjørbæk, and Jeffrey S. Flier Department
More informationYK052 Mouse Leptin ELISA
YK052 Mouse Leptin ELISA FOR LABORATORY USE ONLY YANAIHARA INSTITUTE INC. 2480-1 AWAKURA, FUJINOMIYA-SHI SHIZUOKA, JAPAN 418-0011 Contents Ⅰ. Introduction 2 Ⅱ. Characteristics 3 Ⅲ. Composition 4 Ⅳ. Method
More informationHormones and Neurons
Hormones and Neurons Appetite Regulation and Weight Control The Story of Leptin, Ghrelin, and PYY and the Treatment of Obesity Michael A. Bush, M.D. CA-AACE Annual Meeting Symposium May 5, 2017 1 phat
More informationAn important function of the central nervous
Perspectives in Diabetes Insulin Signaling in the Central Nervous System A Critical Role in Metabolic Homeostasis and Disease From C. elegans to Humans Daniel Porte, Jr., 1,2,3 Denis G. Baskin, 3 and Michael
More informationRequires Signaling though Akt2 Independent of the. Transcription Factors FoxA2, FoxO1, and SREBP1c
Cell Metabolism, Volume 14 Supplemental Information Postprandial Hepatic Lipid Metabolism Requires Signaling though Akt2 Independent of the Transcription Factors FoxA2, FoxO1, and SREBP1c Min Wan, Karla
More informationHISTAMINE INHIBITS EATING WITHOUT ALTERING POSTPRANDIAL SATIETY IN RATS KELLY TSCHANTZ
HISTAMINE INHIBITS EATING WITHOUT ALTERING POSTPRANDIAL SATIETY IN RATS KELLY TSCHANTZ Abstract Exogenous histamine decreases food intake and injection of H-1 antagonists increases food intake in rats.
More informationMetabolic responses to leptin in obese db/db mice are strain dependent
Am J Physiol Regulatory Integrative Comp Physiol 281: R115 R132, 2001. Metabolic responses to leptin in obese db/db mice are strain dependent RUTH B. S. HARRIS, TIFFANY D. MITCHELL, XIAOLANG YAN, JACOB
More informationExtended therapeutic validation of an anti-mc4 receptor antibody in an animal model of anorexia nervosa
Extended therapeutic validation of an anti-mc4 receptor antibody in an animal model of anorexia nervosa (project no. 04-12B) Authors Guus Akkermans, Martien Kas Preliminary data report Introduction In
More informationDaily Intraparaventricular Orexin-A Treatment Induces Weight Loss in Rats
nature publishing group articles Daily Intraparaventricular -A Treatment Induces Weight Loss in Rats Colleen M. Novak 1 and James A. Levine 1 The neuropeptide orexin (hypocretin) increases energy expenditure
More informationMBB317. Dr D MANGNALL OBESITY. Lecture 2
MBB317 Dr D MANGNALL OBESITY Lecture 2 When the structure of the insulin receptor was first discovered it was assumed that the active beta subunit tyrosine kinase would phosphorylate some intracellular
More informationIngestive Behavior: Feeding & Weight Regulation. Hypovolemic vs. Osmotic Thirst
Ingestive Behavior: Feeding & Weight Regulation 1 Hypovolemic Thirst Receptors, CNS, Responses Salt Appetite Digestive components Glucose Homeostasis: Insulin & Glucagon Diabetes Mellitus 1 & 2 CNS Hypothalamic
More informationEnergy Balance Equation
Energy Balance Equation Intake Expenditure Hunger Satiety Nutrient Absorption Metabolic Rate Thermogenesis Activity Eat to Live! Live to Eat! EAT TO LIVE Intake = Expenditure Weight Stable LIVE TO EAT
More informationThe enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans
The enteroinsular axis in the pathogenesis of prediabetes and diabetes in humans Young Min Cho, MD, PhD Division of Endocrinology and Metabolism Seoul National University College of Medicine Plasma glucose
More informationCopyright 2017 The Guilford Press
This is a chapter excerpt from Guilford Publications. Eating Disorders and Obesity: A Comprehensive Handbook, Third Edition. Edited by Kelly D. Brownell and B. Timothy Walsh. Copyright 2017. Purchase this
More informationSURGICAL PROCEDURE DESCRIPTIONS
SURGICAL PROCEDURE DESCRIPTIONS GONADECTOMY: CASTRATION USING SCROTAL METHOD 1. The animal is anesthetized and placed in dorsal recumbency with the tail toward the surgeon. 2. The abdominal and scrotal
More information18s AAACGGCTACCACATCCAAG CCTCCAATGGATCCTCGTTA. 36b4 GTTCTTGCCCATCAGCACC AGATGCAGCAGATCCGCAT. Acc1 AGCAGATCCGCAGCTTG ACCTCTGCTCGCTGAGTGC
Supplementary Table 1. Quantitative PCR primer sequences Gene symbol Sequences (5 to 3 ) Forward Reverse 18s AAACGGCTACCACATCCAAG CCTCCAATGGATCCTCGTTA 36b4 GTTCTTGCCCATCAGCACC AGATGCAGCAGATCCGCAT Acc1
More information1,8 1,6 1,4 1,2 1. EE/g lean mass 0,8 0,6 0,4 0,2. Ambulatory locomotor activity. (beam brakes/48h) V MCH MCHpf 0,86 0,85 0,84 0,83 0,82 0,81 0,8
Supplementary figure 1 vehicle A -pf Energy expenditure (kcal/kg/48h) 25 2 15 1 5 V pf EE/g lean mass 1,8 1,6 1,4 1,2 1,8,6,4,2 Total locomotor activity (beam brakes/48h) C D E 7 6 5 4 3 2 1 V pf Ambulatory
More informationletters to nature ... AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
... AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus Yasuhiko Minokoshi 1, Thierry Alquier 1, Noboru Furukawa 1, Young-Bum Kim 1, Anna Lee 1, Bingzhong
More informationA Central Role of MG53 in Metabolic Syndrome. and Type-2 Diabetes
A Central Role of MG53 in Metabolic Syndrome and Type-2 Diabetes Yan Zhang, Chunmei Cao, Rui-Ping Xiao Institute of Molecular Medicine (IMM) Peking University, Beijing, China Accelerated Aging in China
More informationAnalysis of AVP functions via V1a and V1b receptors with knockout mice. Akito Tanoue
Analysis of AVP functions via V1a and V1b receptors with knockout mice Akito Tanoue Department of Pharmacology, National Research Institute for Child Health and Development Arginine-Vasopressin (AVP) is
More informationTHE PERENNIAL STRUGGLE TO LOSE WEIGHT AND MAINTAIN: WHY IS IT SO DIFFICULT?
THE PERENNIAL STRUGGLE TO LOSE WEIGHT AND MAINTAIN: WHY IS IT SO DIFFICULT? Robert Ferraro, MD Medical Director Southwest Endocrinology Associates, PA Diabetes and Weight Management Center OBESITY The
More informationRuth B. S. Harris, Tiffany D. Mitchell, Xiaolang Yan, Jacob S. Simpson and Stephen M. Redmann, Jr.
Metabolic responses to leptin in obesedb/db mice are strain dependent Ruth B. S. Harris, Tiffany D. Mitchell, Xiaolang Yan, Jacob S. Simpson and Stephen M. Redmann, Jr. Am J Physiol Regul Integr Comp Physiol
More informationAdipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University
Adipose Tissue as an Endocrine Organ Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Functions of Adipose Tissue Adipose tissue expresses and secretes a variety of bioactive peptides,
More informationOver the past three decades there has been an alarming
Differential effects of central fructose and glucose on hypothalamic malonyl CoA and food intake Seung Hun Cha a, Michael Wolfgang a, Yuka Tokutake b, Shigeru Chohnan b, and M. Daniel Lane a,1 a Department
More informationEffect of BI-1 on insulin resistance through regulation of CYP2E1
Effect of BI-1 on insulin resistance through regulation of CYP2E1 Geum-Hwa Lee 1, Kyoung-Jin Oh 2, 3, Hyung-Ryong Kim 4, Hye-Sook Han 2, Hwa-Young Lee 1, Keun-Gyu Park 5, Ki-Hoan Nam 6, Seung-Hoi Koo 2
More informationTHE ROLE OF INSULIN RECEPTOR SIGNALING IN THE BRAIN. COGS 163 By: Pranav Singh Alexandra Villar
THE ROLE OF INSULIN RECEPTOR SIGNALING IN THE BRAIN COGS 163 By: Pranav Singh Alexandra Villar INTRODUCTION Insulin is a hormone produced in the pancreas by the islets of Langerhans that regulates the
More informationEVALUATION OF A SATIETY HORMONE IN PIGS WITH DIVERGENT GENETIC POTENTIAL FOR FEED INTAKE AND GROWTH
EVALUATION OF A SATIETY HORMONE IN PIGS WITH DIVERGENT GENETIC POTENTIAL FOR FEED INTAKE AND GROWTH A.C. Clutter 1, R. Jiang 2, J.P. McCann 3 and D.S. Buchanan 4 Story in Brief Experiments were designed
More informationDeficits in amygdaloid camp-responsive element binding protein signaling play a role in genetic predisposition to anxiety and alcoholism
Research article Related Commentary, page 2697 Deficits in amygdaloid camp-responsive element binding protein signaling play a role in genetic predisposition to anxiety and alcoholism Subhash C. Pandey,
More informationRole of the ventromedial hypothalamic Steroidogenic Factor 1/ Adrenal 4. glucose metabolism in mice.
Role of the ventromedial hypothalamic Steroidogenic Factor 1/ Adrenal 4 Binding Protein neurons in the regulation of whole body energy and glucose metabolism in mice. Eulalia Coutinho Department of Physiological
More informationBi156 lecture 2, 1/6/12. Eating and weight regulation
Bi156 lecture 2, 1/6/12 Eating and weight regulation Introduction: weight regulation in an affluent society In our society much effort and money is expended on regulation of weight. Failure to maintain
More informationThe uses of animal models in the evaluation of functional foods
The uses of animal models in the evaluation of functional foods Jane Chao, Ph.D. Taipei Medical University School of Nutrition and Health Sciences November 30, 2006 1 Content Assessments for health claims
More informationRestoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats
Research article Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats Alessandro Pocai, 1 Tony K.T. Lam, 1 Silvana Obici, 1 Roger Gutierrez-Juarez, 1 Evan
More informationEffects of sitagliptin on cardiac metabolism in mice
Effects of sitagliptin on cardiac metabolism in mice M. Lenski, J.-C. Reil, M. Böhm, U. Laufs Saarland University Hospital Department of Internal Medicine III, Cardiology Homburg - Germany Disclosures
More informationSex Differences in Central Expression and Effects of Brain-Derived Neurotrophic Factor
Sex Differences in Central Expression and Effects of Brain-Derived Neurotrophic Factor Haifei Shi Department of Biology, Miami University International Conference on Endocrinology October 22, 14 Arcuate
More informationIntroduction. S Lin 1, TC Thomas 1, LH Storlien 1 and XF Huang 1 *
(2000) 24, 639±646 ß 2000 Macmillan Publishers Ltd All rights reserved 0307±0565/00 $15.00 www.nature.com/ijo Development of high fat diet-induced obesity and leptin resistance in C57Bl=6J mice S Lin 1,
More informationLeptin and the Central Nervous System Control of Glucose Metabolism
Physiol Rev 91: 389 411, 2011; doi:10.1152/physrev.00007.2010. Leptin and the Central Nervous System Control of Glucose Metabolism GREGORY J. MORTON AND MICHAEL W. SCHWARTZ Diabetes and Obesity Center
More information3-Thia Fatty Acids A New Generation of Functional Lipids?
Conference on Food Structure and Food Quality 3-Thia Fatty Acids A New Generation of Functional Lipids? Rolf K. Berge rolf.berge@med.uib.no Fatty acids- Essential cellular metabolites Concentrations must
More informationResveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network
Resveratrol activates duodenal Sirt1 to reverse insulin resistance in rats through a neuronal network Clémence D. Côté, Brittany A. Rasmussen, Frank A. Duca, Melika Zadeh-Tahmasebi, Joseph A. Baur, Mira
More informationNeural pathways controlling homeostatic and hedonic feeding in rats on free-choice diets van den Heuvel, J.K.
UvA-DARE (Digital Academic Repository) Neural pathways controlling homeostatic and hedonic feeding in rats on free-choice diets van den Heuvel, J.K. Link to publication Citation for published version (APA):
More informationSupplementary Figure 1
Supplementary Figure 1 Supplementary Figure 1 Schematic depiction of the tandem Fc GDF15. Supplementary Figure 2 Supplementary Figure 2 Gfral mrna levels in the brains of both wild-type and knockout Gfral
More informationFor pair feeding, mice were fed 2.7g of HFD containing tofogliflozin
Materials and Methods Pair Feeding Experiment For pair feeding, mice were fed 2.7g of HFD containing tofogliflozin (0.005%), which is average daily food intake of mice fed control HFD ad libitum at week
More informationWhy Obesity Is A Chronic Disease
Why Obesity Is A Chronic Disease Arya M Sharma, MD, FRCP(C) Professor of Medicine Chair in Obesity Research & Management University of Alberta Edmonton, AB, Canada www.drsharma.ca Global Obesity Map 2014
More informationMary ET Boyle, Ph. D. Department of Cognitive Science UCSD
Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD Is obesity a brain disorder? What is the evidence to support obesity is a brain disorder? Environmental, biological, and behavioral issues Over
More informationFOOD REWARD AND MODULATION BY NUTRITIONAL STATUS, INSULIN AND LEPTIN. Dianne Figlewicz Lattemann, Ph.D.
FOOD REWARD AND MODULATION BY NUTRITIONAL STATUS, INSULIN AND LEPTIN Dianne Figlewicz Lattemann, Ph.D. ECOR SYMPOSIUM FEBRUARY 23, 2006 PASSION LIVES HERE, TOO Model for regulation of body adiposity Hypothalamic
More informationChanges and clinical significance of serum vaspin levels in patients with type 2 diabetes
Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes L. Yang*, S.J. Chen*, G.Y. Yuan, D. Wang and J.J. Chen Department of Endocrinology, Affiliated Hospital of Jiangsu
More informationperk/erk STAT5B
pakt/akt relative to saline (fold).5.5.5 control perk/erk relative to saline (fold).6.4..8.6.4. p=.6 control db/+ Hsp6 VDAC Hsp6/VDAC (relative to db/+) 8 6 4 db/+ C db/+ Hsp6 Hsp6/actin (relative to db/+)
More informationDiabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs
Diabesity Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Abdominal obesity Low HDL, high LDL, and high triglycerides HTN High blood glucose (F>100l,
More informationChoosing What You Eat and Why. Chapter 1 BIOL1400 Dr. Mohamad H. Termos
Choosing What You Eat and Why Chapter 1 BIOL1400 Dr. Mohamad H. Termos Objectives Following this lecture, you should be able to describe: - Nutrition definition - Sources of nutrients - Energy sources
More informationLeptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice
Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice Atherosclerosis, 2007 Chiba T, Shinozaki S, Nakazawa T, et al. Present by Sudaporn Pummoung Apolipoprotein E (apoe( apoe)
More informationLeptin: Amenorrhea, Reproduction, Anorexia. Hazel Leung, Ahrad Nathan, Seja Saddy, Judy Tang
Leptin: Amenorrhea, Reproduction, Anorexia Hazel Leung, Ahrad Nathan, Seja Saddy, Judy Tang Introduction: What is leptin? Adipocyte-derived hormone (WAT) Receptor roles Class I cytokine receptor superfamily
More information